Parkinson's in the Media

Sleep-Punching Disorder May Be Linked to Parkinson's
NBC News
For reasons that are still unclear, REM sleep behavior disorder also seems to increase a person's risk for Parkinson's disease and one type of dementia.  Some studies have suggested that more than 50 percent of those with this rare sleep disorder may go on to develop a neurodegenerative disease.  To learn more, a recent study published in the journal Neurology tried to determine the risk factors for RBD and whether they were similar to those for Parkinson's disease or dementia.  More…

FDA’s Claims Over Stem Cells Upheld
Nature
A court decision on 23 July could help to tame the largely unregulated field of adult stem-cell treatments.  The US District Court in Washington DC affirmed the right of the Food and Drug Administration (FDA) to regulate therapies made from a patient’s own processed stem cells.  The case hinged on whether the court agreed with the FDA that such stem cells are drugs.  More…

Parkinson’s Disease Treatment:  An Interview with Ted Dawson
News Medical
Question:  It was reported that your recent research into treatments for Parkinson’s disease used adult stem cells.  Please could you explain what adult stem cells are?  Answer:  We didn’t actually use adult stem cells; we used induced pluripotent stem (IPS) cells. We took skin cells from patients without Parkinson’s disease and from those with different forms of Parkinson’s disease.  Then we converted them to inducible pluripotent stem cells using established protocol.  More…

Max Little: A Test for Parkinson’s with a Phone Call
TED Talks
Parkinson’s disease affects 6.3 million people worldwide, causing weakness and tremors, but there's no objective way to detect it early on.  Yet.  Applied mathematician and TED Fellow Max Little is testing a simple, cheap tool that in trials is able to detect Parkinson's with 99 percent accuracy – in a 30-second phone call.   More…

Rejected Drug Could Protect Against Parkinson's and Alzheimer's
Medical News Today
The journal Molecular Psychiatry recently featured two studies on latrepirdine, known as Dimebon, which revealed that the second study could be a new potential for the compound to treat Parkinson's, Alzheimer's disease, sleep disorders as well as other neurodegenerative conditions.  The international study, which was led by researchers from Mount Sinai School of Medicine, discovered that latrepiridine reduced the level of at least two neurodegeneration-related proteins in mice.  Over 5 million people worldwide suffer from Alzheimer's disease, an incurable, progressive neurodegenerative disease that is the leading cause of dementia in the elderly, whilst around 1 million people in the U.S. suffer from Parkinson's disease, a progressive disorder that leads to muscle stiffness, tremors and slowed movements and gait.  More…

UF Parkinson's Disease Researcher Wins Patient Advocacy Prize
WXTL, Tallahassee’s ABC Affiliate
In recognition of her efforts on behalf of patients with Parkinson’s disease, a University of Florida researcher has been honored by a noted national advocacy organization.  Elizabeth Stegemöller, Ph.D., a postdoctoral fellow in the College of Health and Human Performance and the UF Center for Movement Disorders and Neurorestoration, has received the 2012 Parkinson’s Action Network Postdoctoral Advocacy Prize.  More…

Lisa Shulman | People on the Move
Baltimore Business Journal
Lisa Shulman, M.D., professor of neurology at the University of Maryland School of Medicine, received the Researcher Advocacy Prize from the Parkinson’s Action Network.  This national award honors members of the scientific community for their advocacy and community outreach work.  More…

Bob Hoskins Has Parkinson's Disease, Retiring from Acting
Reuters
Veteran British actor Bob Hoskins, the star of "Who Framed Roger Rabbit," said on Wednesday he had been diagnosed with Parkinson's disease and was retiring from acting.  "Bob Hoskins wishes to announce that he will be retiring from acting, following his diagnosis of Parkinson's disease last autumn.  He wishes to thank all the great and brilliant people he has worked with over the years, and all of his fans who have supported him during a wonderful career," the actor's London representatives said in a statement.  More…


Back to August 2012 Monthly Message